Key Segmentation
By Product
-
Angiography Systems
-
Catheters
-
Guidewires
-
Contrast Media
-
Others
By Technology
-
X-Ray Angiography
-
CT Angiography
-
MR Angiography
-
Others
By Application
-
Coronary Angiography
-
Neurovascular Angiography
-
Peripheral Angiography
-
Others
By End User
-
Hospitals
-
Ambulatory Surgical Centers
-
Diagnostic Imaging Centers
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key players include Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Canon Medical Systems Corporation, Shimadzu Corporation, Boston Scientific Corporation, Terumo Corporation and Abbott Laboratories.
Key opportunities include new installations in emerging markets, hybrid rooms for stroke and structural heart care, and outpatient procedure centers.
The major growth factor is the rising burden of heart disease and stroke, together with the shift to minimally invasive catheter-based treatment.
By Product, the Angiography Systems segment dominated the market in 2025 with an estimated 44.00% share, supported by the high price of fixed C-arm systems in catheterization laboratories.
North America dominated the market with a share of 37.50% in 2025, driven by high procedure volumes, reimbursement and quick adoption of new imaging software.
